Cancer
Fluoroquinolone Resistance in Bacteremic and Low-Risk Febrile Neutropenic Patients with Cancer
A study conducted by researchers at Fudan University in Shanghai, China, has raised concerns about the effectiveness of fluoroquinolone-based oral treatment for low-risk febrile neutropenic patients with cancer. The study, published in BMC Cancer, found that a significant number of Escherichia coli isolates from these patients showed high levels of